← FDA Drug Approvals (Drugs@FDA)

BRIMONIDINE TARTRATE AND TIMOLOL MALEATE

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: UPSHER SMITH LABS · Approved 2022-12-12

Drug application

FDA Application #
ANDA215598
Application type
Abbreviated New Drug Application (Generic)
Brand name
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Generic name
BRIMONIDINE TARTRATE AND TIMOLOL MALEATE
Active ingredients
BRIMONIDINE TARTRATE; TIMOLOL MALEATE
Dosage form
SOLUTION/DROPS
Route
OPHTHALMIC
Marketing status
Prescription
Sponsor
UPSHER SMITH LABS
Manufacturer
Upsher-Smith Laboratories, LLC
First approval
2022-12-12

Source

Authoritative
Drugs@FDA application overview
Machine
JSON-LD · Markdown